초록 ▼

An infant food formulation substantially approximating human milk in fatty acid composition comprising a mixture of DHA and EPA in a ratio of approximately 3:2 by weight, immunoglobulins to mimic the immunoglobulin content of mother\s milk, a source of protein, a source of carbohydrate, a source of

An infant food formulation substantially approximating human milk in fatty acid composition comprising a mixture of DHA and EPA in a ratio of approximately 3:2 by weight, immunoglobulins to mimic the immunoglobulin content of mother\s milk, a source of protein, a source of carbohydrate, a source of ash, and sufficient water to provide an easily assimilable infant formula, the DHA, the EPA, and the immunoglobulins being encapsulated in capsules having a diameter of less than 350m

대표청구항 ▼

An infant food formulation substantially approximating human milk in fatty acid composition, comprising: a mixture of 4,7,10,13,16,19-docosahexaenoic acid (DHA) and 5,8,11,14,17-eicosapentaenoic acid (EPA) in a ratio of approximately from 1:1 to 2:1 by weight, the EPA and DHA being present in a quan

An infant food formulation substantially approximating human milk in fatty acid composition, comprising: a mixture of 4,7,10,13,16,19-docosahexaenoic acid (DHA) and 5,8,11,14,17-eicosapentaenoic acid (EPA) in a ratio of approximately from 1:1 to 2:1 by weight, the EPA and DHA being present in a quantity substantially to mimic the relative quantity of fatty acid in human mother\s milk; immunoglobulins in a quantity substantially to mimic the immunoglobulin content of human mother\s milk; a source of protein in a quantity substantially to mimic the protein content of human mother\s milk; a source of carbohydrate in a quantity substantially to mimic the carbohydrate content of human mother\s milk; and sufficient water to provide an easily assimilable infant formula, said DHA and EPA and said immunoglobulins being microencapsulated.